Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Castration-Resistant Prostate Cancer
NCT01243385Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Dec 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in prostate cancer (PCa), sponsored by Swiss Group for Clinical Cancer Research. Started Dec 2010; status: completed.
02
Drugs
metformin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01243385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243385.